EP Global Communications Inc fka EPGL

[dmarkg]

EPGL 4th Q and A Investor Relations 11.28.12 Archived

EPGL Med @EPGLMed
Good Evening. Welcome to tonight's Q&A which will go until 6:30PM EST or until no more questions, whichever is first.

EPGL Med @EPGLMed
Yes, to clarify: 499 mm outstanding 5B authorized. Approx 4.5B will be restricted Approximately 499mm outstanding float foreseeable future.

EPGL Med @EPGLMed
BioMems is Biological Microelectromechanical Systems.

EPGL Med @EPGLMed
Yes, this is the leading edge of medicine treatment and diagnosis, delivery of drugs and implantable devices.


EPGL Med @EPGLMed
We will be continuing to update OTC to Current information. Then we will begin process to become OTCQX. Our goal is to put EPGL on Nasdaq or NYSE. This will take some time to accomplish, but this is the plan.

EPGL Med @EPGLMed
The balance sheet reflects all assets EPGL has as listed.

EPGL Med @EPGLMed
With the technologies we have in development and the team of people we have , yes we believe the valuations are if anything, conservative.

EPGL Med @EPGLMed
That does not mean, however that market events and developments with competition, cannot have an impact on values. But we are confident that the technologies we have in house, have significant value going forward in the medical device industry.

EPGL Med @EPGLMed
Without being specific, the core technology we are developing in BioMems has several device applications that will result. Many many, apps.

EPGL Med @EPGLMed
Yes, we are accepting pre-orders on MPDD and we continue to have great demand and interest building for the rollout in 2013.

EPGL Med @EPGLMed
Accuracy and precise delivery of diagnosis and treatment is the mission of EPGL devices. We are on that track with our developing pipeline.

EPGL Med @EPGLMed
Matt, tonight's session will not give specific dates and times on any releases yet. We do not want to do that until closer to the time.

EPGL Med @EPGLMed
Matt, EDGAR filings will be coming in the future as we continue to climb the OTC Tiers. Maybe sooner than later. We shall see.

EPGL Med @EPGLMed
We have sent a test marketing piece for the MPDD to approximately 5,000 Physicians. We have had a tremendous response resulting in several hundred placements in line for pre-orders and requests for more info.

EPGL Med @EPGLMed
We will continue priming physicians worldwide with pre-marketing materials which result in direct response.

EPGL Med @EPGLMed
However, when the MPDD is rolled out, we will be utilizing the services of a major distribution channel to be announced.

EPGL Med @EPGLMed
We have not accepted any offers as yet from organizations wishing to purchase major blocks of equity. That is still being evaluated.

EPGL Med @EPGLMed
We enjoy a close connection with the US Military and anticipate a good relationship going forward, utilizing the technologies we have.

EPGL Med @EPGLMed
Because of fluid developments with potential financial investors and partners, we are keeping certain key board positions and
Officer positions open until such time as we can solidify discussions going on presently. As soon as we know, you will know immediately.

EPGL Med @EPGLMed
Thanks to all. Have a great evening. We will do this regularly.


..............


My current questions have been answered, I am satisfied with this undervalued gift. The following you just read were from EPGL responses to questions sent to them and the time expired past 6:30pm EST. (3:30pm Pacific Standard Time) From 11.28.12